Our Privacy Statment & Cookie Policy

All LSEG websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

July 19, 2021

Chart of the Week: UK ‘Freedom day’ go-ahead amid supply concerns

by Fathom Consulting.

England is pressing ahead with easing most remaining COVID-19 restrictions today, despite a sharp rise in new cases (see blue line in chart). The decision comes as the link between new cases and COVID-related hospital admissions and deaths (orange line in chart) seems to have been broken, given that a large share of the England’s adult population has been fully vaccinated. On the whole, this should be good news for the UK economy, in particular sectors such as hospitality and events. However, while many restrictions are being lifted, it is believed that more than 500,000 people in the UK have been told to self-isolate; not everybody is able to work from home, meaning that many businesses are facing staff shortages, which could lead to supply bottlenecks. This, coupled with strong demand, is likely to add to inflationary pressures, at least in the short run.

 

Refresh this chart in your browser | Edit the chart in Datastream

Join a growing community of asset managers and stay up to date with the latest research from Refinitiv and partners to help you inform your investment decisions. Follow our Asset Management LinkedIn showcase page.

________________________________________________________________________________________

Refinitiv Datastream

Financial time series database which allows you to identify and examine trends, generate and test ideas and develop view points on the market.

Refinitiv offers the world’s most comprehensive historical database for numerical macroeconomic and cross-asset financial data which started in the 1950s and has grown into an indispensable resource for financial professionals. Find out more.

Get In Touch

Subscribe

We have updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.x